Tech Company Financing Transactions
DiaKine Therapeutics Funding Round
On 9/3/2008, DiaKine Therapeutics secured investment from BlueTree Allied Angels.
Transaction Overview
Company Name
Announced On
9/3/2008
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
338 Raleigh Avenue
Norfolk, VA 23507
USA
Norfolk, VA 23507
USA
Phone
Website
Email Address
Overview
DiaKine Therapeutics, Inc. is a start-up biopharmaceutical company developing new, proprietary drugs for unmet medical needs in diabetes and complications related to diabetes. These drugs have the potential to restate the diabetes market by stopping the progression of diabetes and reversing damage already caused by the disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Keith Ignotz
Chief Operating Officer
Mary Nadler
Chief Scientific Officer
Jerry Nadler
Browse more venture capital transactions:
Prev: 9/3/2008: Secure64 Software venture capital transaction
Next: 9/3/2008: Interlace Medical venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs